The Department of Health and Human Services terminated a $766 million contract with Moderna to develop an mRNA bird flu vaccine, citing concerns about the mRNA technology’s safety and lack of transparency. This decision, despite Moderna’s reporting of positive interim results from a Phase 1/2 study, shifts federal funding priorities toward vaccine platforms with established safety profiles. Critics argue this cancellation jeopardizes pandemic preparedness, particularly given the evolving threat of H5N1 avian flu and the limited availability of alternative vaccine production methods. The move has drawn sharp criticism from public health experts who warn of increased risks to the American public.
Read More
The US cancellation of over $700 million in funding for Moderna’s bird flu vaccine is a deeply concerning development. This decision, made under the Trump administration, effectively halts progress on a crucial vaccine, leaving the nation vulnerable to a potential avian influenza pandemic. The timing of the cancellation, just four months after the initial funding allocation, raises serious questions about the decision-making process and its implications for public health. It’s baffling how such a significant investment in pandemic preparedness could be so abruptly reversed.
This cancellation is not merely a financial setback; it represents a failure to prioritize prevention. The argument that “an ounce of prevention is worth a pound of cure” rings especially true here, as investing in vaccine development before an outbreak is significantly more cost-effective and less devastating than responding to a widespread pandemic.… Continue reading
The World Health Assembly overwhelmingly adopted the world’s first pandemic accord, aiming to improve international cooperation and response to future outbreaks. The agreement emphasizes strengthening health systems, sharing resources equitably, and establishing a mechanism for sharing pathogen information. Notable, however, was the absence of the United States, which withdrew from the WHO under the Trump administration, citing mishandling of the COVID-19 pandemic. Despite criticism from a U.S. representative who called for a WHO overhaul, the agreement was lauded by global leaders as a significant step towards pandemic preparedness.
Read More
After years of negotiations, nations have reached a landmark agreement on a global pandemic accord, outlining measures for prevention, preparedness, and response. A key element is a pathogen access and benefit-sharing system designed to ensure more equitable distribution of vaccines, drugs, and diagnostics during future outbreaks, addressing inequities seen during the COVID-19 pandemic. While the details remain to be finalized, the treaty mandates the timely sharing of information and requires manufacturers to provide a minimum percentage of their products to the WHO. The agreement’s adoption and ratification by member states are the next crucial steps.
Read More
German intelligence agencies have concluded that the COVID-19 virus likely originated from a laboratory leak. This assessment, while not offering specifics on the indicators leading to this conclusion, highlights a significant shift in the narrative surrounding the pandemic’s origins. The lack of detail is frustrating, leaving many to wonder what specific evidence formed the basis of this high-probability conclusion. It’s easy to imagine the international political fallout such a claim might spark, with immediate denials and accusations of smear campaigns from certain quarters.
The geographical distribution of the virus further fuels this suspicion. The genetically closest relatives of the virus are found in cave bats in Yunnan province, hundreds of kilometers from Wuhan.… Continue reading
Avian flu, or H5N1, has devastated US poultry farms, killing over 156 million birds and causing egg prices to surge. Farmers are implementing stringent biosecurity measures, but the crisis continues, forcing difficult decisions like accepting chicks from potentially infected areas to avoid leaving farming. The outbreak’s worsening coincides with proposed government funding cuts to research and response efforts, raising concerns about pandemic preparedness. The Trump administration is developing a new strategy focused on prevention and vaccination, while moving away from culling infected flocks, although the effectiveness of this approach is debated.
Read More
Bird flu, specifically the highly pathogenic avian influenza (HPAI), is currently widespread in Massachusetts, according to a joint statement released by state health and environmental officials. This concerning development has prompted officials to advise the public to avoid handling any birds or animals that appear sick or are deceased, urging immediate reporting of suspected cases to relevant authorities. The widespread nature of the outbreak suggests HPAI’s presence extends beyond confirmed positive cases, prompting increased vigilance and proactive measures.
The state agencies involved—the Division of Fisheries and Wildlife, the Department of Agricultural Resources, and the Department of Public Health—are collaborating on testing suspected cases and coordinating safe disposal methods for deceased birds.… Continue reading
Following a memo from a CDC official, all collaboration between the CDC and the WHO has been immediately suspended, halting joint efforts on combating outbreaks like Marburg virus and mpox. This abrupt action, surprising to experts, contradicts the previously announced phased withdrawal from the WHO and is expected to hinder global health initiatives. The suspension impacts crucial information sharing and expertise exchange, potentially jeopardizing U.S. and global health security. This comes alongside a freeze on PEPFAR funding, further impacting global health efforts.
Read More
To address budget constraints, the WHO is implementing cost-cutting measures including a hiring freeze (except for critical roles), significant travel reductions, and limitations on IT replacements and capital investments. These actions follow internal calls for increased efficiency and resource mobilization. External criticism of these cuts highlights potential negative consequences for global pandemic preparedness, particularly given recent challenges with misinformation. Further budget reductions are anticipated, and political pressure to withdraw from the WHO, as evidenced by proposals in Italy, adds to the organization’s challenges.
Read More
The Department of Health and Human Services (HHS) recently awarded Moderna a substantial $590 million grant to accelerate the development of an mRNA vaccine against avian influenza, specifically the H5N1 strain. This significant investment underscores the growing concern surrounding the potential for a widespread bird flu outbreak.
The high mortality rate associated with H5N1, particularly among elderly individuals and young children, is a major cause for alarm. Estimates suggest a mortality rate nearing 50% in these vulnerable populations, raising the specter of a severely strained healthcare system, especially considering the lingering effects of the COVID-19 pandemic on already overburdened hospitals, particularly in rural areas.… Continue reading
John Q. Hosedrinker 
Matt Underwood